Introduction
============

Neurodevelopmental disorders including schizophrenia, autism spectrum disorder (ASD) and gender dysphoria (GD) are thought to be multifactorial diseases. Genetic factors as well as environmental factors including life events are involved in their pathogenesis.

Schizophrenia is a chronic, debilitating psychiatric illness with a worldwide prevalence of 1%. A number of genetic studies have shown that schizophrenia has a high heritability and is strongly influenced by genetic factors. Several twin studies show that the concordance rate for schizophrenia between MZ twins is 41--79%, and 0--14% between dizygotic twins.^[@bib1]^ ASD is a heterogeneous, behaviorally defined, neurodevelopmental disorder that occurs in 1 in 150 children, characterized by deficits in communication, impaired social interaction and restricted patterns of behavior. Twin studies of ASD have demonstrated a significantly higher concordance rate for MZ twins (70--90%) than for dizygotic twins (0--10%).^[@bib2],[@bib3]^ Previously referred to as gender identity disorder, GD is a condition where a person experiences discomfort or distress due to a mismatch between their biological sex and gender identity. Twin studies of GD also show high concordance rates in MZ twins.^[@bib4]^ The higher concordance rate in MZ rather than dizygotic twins in these conditions suggests a contributory role for hereditary factors. A number of family and twin studies have shown that genetic factors play an important role in the onset of various neurodevelopmental disorders.

Phenotypically discordant MZ twins are interesting resources for genetic studies in diseases with a high concordance rate, and can make twin studies helpful in identifying the causative genes for heritable diseases. Identifying the molecular genetic differences between discordant MZ twins can help to elucidate the molecular mechanisms that underlie phenotypic discordance. To date, only a few studies have successfully detected genetic differences such as repeat length, single nucleotide variants (SNVs) and copy number variants (CNVs) between discordant MZ twins.^[@bib5],[@bib6],[@bib7]^

A number of genetic studies for neurodevelopmental disorders have been reported; however, because of genetic heterogeneity, their pathogenesis is still unclear. To identify causative genes for neurodevelopmental disorders, we performed WES and deep sequencing in five pairs of MZ twins with discordant neurodevelopmental disorders and one healthy control MZ twin. Here, we describe the results of WES and deep sequencing to identify discordant variants between MZ twins.

Materials and methods
=====================

Subjects
--------

Subjects were three pairs of MZ twins with discordant schizophrenia, one pair of MZ twins with discordant GD, one pair of MZ twins with discordant ASD and their parents, one pair of healthy MZ twins and two unrelated healthy volunteers as normal controls. In all twin pairs, the onset of neuropsychiatric conditions had occurred 10 years earlier. Detailed information was summarized in [Table 1](#tbl1){ref-type="table"}. All patients were diagnosed with psychiatric diseases according to the International Classification of Diseases, revision 10 and Diagnostic and Statistical Manual of Mental Disorders, fifth edition by two experienced psychiatrists. Peripheral blood samples, 10 ml each, were collected after obtaining written informed consent, and genomic DNA was extracted from blood lymphocytes using QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany). Experimental procedures were approved by the Committee for the Ethical Issues on Human Genome and Gene Analysis at Nagasaki University.

Whole-exome sequencing
----------------------

For WES, subjects' genomic DNA samples were enriched using SureSelect Human All Exon V5 (Agilent Technologies, Santa Clara, CA, USA) according to manufacturer's protocol. Enriched genomic libraries were sequenced with HiSeq2500 (Illumina, CA, USA).

Sequencing data analysis
------------------------

Fastq format files were generated by the bcl2fastq software for HiSeq2500 and by the MiSeq Reporter software for MiSeq (Illumina). The Novoalign software (Novocraft, Selangor, Malaysia) was used to align reads on the hg19/GRCh37 human reference genome sequence. Aligned reads were sorted by the Novosort software (Novocraft) and were subjected to marking of PCR and optical duplication by MarkDuplicates in the Picard tools package (<http://broadinstitute.github.io/picard/>).

The Genome Analysis Toolkit^[@bib8]^ was used to perform local realignment (Genome Analysis Toolkit IndelRealigner) and variant call (Genome Analysis Toolkit HaplotypeCaller) implemented an in-house workflow management tool.^[@bib9]^ WES data was applied to eXome-Hidden Markov Model^[@bib10]^ analysis for detecting discordant CNVs within the MZ twins.

SNVs and insertion/deletion (Indels) were annotated using the ANNOVAR software.^[@bib11]^ Mutations that met the following criteria were selected as 'deleterious' mutations: (1) mutations: lead stop gain, stop loss, nonsynonymous or splice site mutations according to GENCODE basic version 19 downloaded from the UCSC genome browser; (2) alternative allele frequencies at mutation loci ⩽0.5% in the following databases: 1000 genome project all populations data released October 2014;^[@bib12]^ NIH NHLBI 6515 exome data (<http://evs.gs.washington.edu/EVS/>); Exome Aggregation Consortium 65000 exome data;^[@bib13]^ Human Genomic Variation Database exome data of 1,208 individuals collected in Japan;^[@bib14]^ SNV allele frequency collected from whole-genome sequencing data of 2,049 healthy Japanese population (<https://ijgvd.megabank.tohoku.ac.jp>) and (3) mutations not included in the UCSC segmental duplication region. To find genomic differences in discordant MZ twins, SNVs and indels were selected based on the following criteria: (1) the patient of the twin pair is not a reference homozygote, (2) a sibling of the twins is a reference homozygote and (3) a deleterious mutation. Average mean depth of all samples was 88.93 and average coverage rate of \>×10 depth regions was 97.53%. Mean depth and coverage rate of all samples were summarized in [Supplementary Table 4](#xob1){ref-type="supplementary-material"}.

Sanger sequencing
-----------------

We designed primers for discordant genotype loci between twins in WES. All primers were designed using Primer3.^[@bib15]^ Genomic DNA (5 ng) was amplified using KOD FX Neo polymerase (TOYOBO, Osaka, Japan) by PCR in 20 μl reactions. PCR mixtures were thermal cycled 32 times in the following conditions after initial denaturation at 94 °C for 2 min: denaturation 98 °C for 10 s, annealing 60 °C for 15 s, extension 68 °C for 30 s and final extension at 68 °C for 5 min. The PCR products were purified with the AMPureXP (Agencourt, Beverly, MA, USA) and sequence reactions were performed using the BigDye Terminator Cycle Sequencing Kit v3.1 (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions. After purification using the CleanSEQ (Agencourt), the products were separated on an ABI Genetic Analyzer 3130 (Applied Biosystems) and the electropherograms were evaluated using the 4Peaks software (<http://nucleobytes.com/4peaks/>).

Deep sequencing
---------------

PCR primers amplifying all candidate loci were designed using Primer3. Amplification was performed as for Sanger sequencing described above. PCR amplicons were mixed in every sample. Mixed PCR amplicons was sonicated to a size of 180 bp using Covaris E220 (Covaris, Wobum, MA, USA). End-repair, A-tailing and adapter ligation were prepared according to manufacturer's protocol for KAPA HTP Library Preparation Kits for Illumina Platforms. After adapter ligation, samples were amplified using KAPA HiFi HotStart Ready Mix (KAPA Biosystems, Wilmington, MA, USA) by PCR with indexed primers. Samples were thermal cycled seven times under the following conditions after initial denaturation at 98 °C for 45 s: denaturation 98 °C for 15 s, annealing 60 °C for 30 s, extension 72 °C for 30 s and final extension at 72 °C for 1 min. Prepared amplicon libraries were sequenced by MiSeq (Illumina). Mutant alleles of candidate loci were counted using Integrative Genomics Viewer.^[@bib16]^ Mean depths of all samples were summarized in [Supplementary Table 5](#xob1){ref-type="supplementary-material"}. To conform the discordant mutant alleles of three loci (chr5:147774428; T\>G, chr6:169051385; A\>G, chr8:442616; A\>G) detected in GD twins, we performed resequencing analysis by Miseq (Illumina) using newly designed PCR primers and high fidelity Taq polymerase (KAPA HiFi Hot Start Ready Mix). Read depths of resequencing analysis was summarized in [Supplementary Table 6](#xob1){ref-type="supplementary-material"}.

Discordant CNV validation
-------------------------

A Droplet Digital PCR (ddPCR) QX200 system (Bio-Rad Laboratories, Hercules, CA, USA), was used to perform ddPCR to confirm copy number change. PCR primers amplifying all three candidate loci and reference primers within the *GNAS* and *RPPH1* genes were designed using Primer3. Ten nanograms of genomic DNA and 2 μM primer pair were added to the 20 μl PCR mixture containing 10 μl 2×EvaGreen Supermix (Bio-Rad). Subsequently, 70 μl Droplet Generator Oil for EvaGreen (Bio-Rad) was added and droplet generation was performed using a DX200 Droplet Generator following manufacturer's protocol. The micro-reactor emulsion was thermal cycled 40 times under the following conditions after initial denaturation at 95 °C for 30 s: denaturation 95 °C for 30 s, annealing and extension 62 °C for 2 min, signal stabilization 4 °C for 5 min, then 90 °C for 5 min. Amplified droplet number was counted using a QX200 Droplet Reader (Bio-Rad). Absolute droplet numbers of *RPPH1* gene were used to calculate the copy number of three candidate loci with *GNAS* gene as control. Absolute droplet numbers of target loci were divided by that of *RPPH1* gene, then multiplied by two to calculate the relative copy number.

Results
=======

Evaluation of single-variant nucleotides and short indels
---------------------------------------------------------

We performed WES to identify discordant heterozygous SNVs and short indels present in affected individuals. Clinical phenotypes of all samples are summarized in [Table 1](#tbl1){ref-type="table"}. A total of 72 discordant SNVs and indels calls were detected on WES ([Supplementary Table 1](#xob1){ref-type="supplementary-material"}). We then validated these calls by capillary sequencing and deep sequencing using MiSeq (Illumina).

A total of 22 loci could not be amplified by Sanger sequencing due to technical difficulties. Of the 50 loci validated by Sanger sequencing, 11 were concordant heterozygous variants (both affected and co-twin have same variants) and 39 loci were concordant with reference alleles. Sanger sequencing did not identify any obvious discordant heterozygous variants (SNVs/indels) ([Supplementary Table 2](#xob1){ref-type="supplementary-material"}).

Subsequently, we performed deep sequencing to more accurately evaluate the allele frequency of mutant alleles in these samples. Eight loci could not be sequenced. Of the 64 loci for which the allele frequency of mutant alleles could be evaluated, 61 did not show any difference of allele frequency between twins, while 3 showed clear discordant mutation allele frequency dominantly in patients. All three discordant loci were in the GD-affected twin. We confirmed the results by resequencing analysis using newly designed PCR primers and high fidelity Taq polymerase ([Figure 1](#fig1){ref-type="fig"}, [Supplementary Table 2](#xob1){ref-type="supplementary-material"}).

Analysis of CNV
---------------

CNV was suspected for three candidate loci on eXome-Hidden Markov Model analysis ([Table 2](#tbl2){ref-type="table"}), so we validated these candidate CNV loci by ddPCR. However, there was no CNV in the three candidate loci ([Figure 2](#fig2){ref-type="fig"}). Due to CNV from 4--7 copies among samples at 14q32.33, structural variations such as duplication would likely exist in this region.

*In silico* analysis of mutations with discordant allele frequency
------------------------------------------------------------------

We used the Polyhen_2,^[@bib17]^ SIFT^[@bib18]^ and PROVEN^[@bib19]^ programs to confirm whether these three variants affect protein function. All programs determined these three variants were 'damaging' ([Table 3](#tbl3){ref-type="table"}).

Discussion
==========

In this study, we report the successful detection of genomic differences between MZ twins discordant for GD. Three genomic changes dominant in affected individuals were confirmed by 'deep sequencing' and subsequent WES in MZ twin pairs. To the best of our knowledge, some studies have successfully identified somatic mutations between discordant MZ twins by several methods including Sanger sequencing, pyrosequencing and fluorescence *in situ* hybridization.^[@bib6],[@bib20],[@bib21]^ However, many twin studies could not identify genomic differences between MZ twin pairs. We previously reported a DNA microarray-based comparison between three pairs of discordant MZ twins with schizophrenia and we also were unable to identify any differences.^[@bib22]^ Two recent studies also attempted unsuccessfully to confirm discordant mutations by WES and Sanger sequencing in discordant MZ twin pairs.^[@bib23],[@bib24]^ Our results from deep sequencing show that variant allele frequencies of all three variants were \~10%, suggesting a small percentage of somatic cell mosaicism with mutation, too small to be identified by Sanger sequencing. Our findings suggest that somatic cell mosaicism may contribute to obscure genomic differences between MZ twins. Deep sequencing facilitates the detection of genomic differences even with low allele frequency in somatic mosaicism by read depth count between MZ twins using NGS.^[@bib25]^ Given that our deep sequencing results could also detect low allele frequency in somatic mosaicism, deep sequencing is an adequate method for detecting somatic mosaic mutations.

Nonetheless, deep sequencing also has some limitations when used to detect low allele frequency mutations. We found one locus that appeared as a low-frequency allele mutation on deep sequencing analysis in both twins and their father ([Supplementary Figure 1A](#xob1){ref-type="supplementary-material"}, [Supplementary Table 3](#xob1){ref-type="supplementary-material"}). However, Sanger sequencing showed that locus to be a heterozygous mutation. This highlights the phenomenon whereby heterozygous mutations appear as low allele frequency mutations on NGS data analysis. Therefore, when analyzing NGS data, it is important to compare allele frequency with other samples for detecting somatic mosaic mutation. Also, two loci showing low allele frequency mutations among all ASD family members ([Supplementary Figure 1B](#xob1){ref-type="supplementary-material"}, [Supplementary Table 3](#xob1){ref-type="supplementary-material"}). It is highly likely that those loci were false-positive calls caused by nonspecific PCR amplification or alignment errors when using NGS.

Twin studies of GD demonstrated higher concordance rates in MZ and suggested a strong heritable component to GD.^[@bib4],[@bib26],[@bib27]^ Postmortem brain studies in GD have shown the size of the bed nucleus of the stria terminalis in male-to-female transsexuals was closer to typical female size than to male size,^[@bib28],[@bib29]^ but the volume and number of neurons were similar to that of a biological male.^[@bib30]^ These results suggest some neurological etiology underlying the development of GD. Even with low-level mosaicism in peripheral blood samples, somatic mutations can cause neurological diseases such as epilepsy and intellectual disability.^[@bib31]^ In silico analysis showed that the effects of all three mutations were 'damaging'. F-box protein 38 (*FBXO38*) gene are known as modulator of Küppel-like transcription factor 7 and the missense substitution of *FBXO38* gene cause spinal muscular atrophies.^[@bib32]^ In addition, homozygous mutation in *SPARC*-related modular calcium-binding 2 (*SMCO2*) gene cause sever developmental dental defect^[@bib33]^ and the potential role of fetal gonad in developmental stage are reported.^[@bib34]^ Specifically, testis development-related protein (*TDRP*) gene was found to be important in spermatogenesis and male infertility,^[@bib35],[@bib36]^ and may be related to maleness. In this context, any of 3 genes could be disease-causing genes.

Recently, Ye *et al* performed whole-genome sequencing in two pairs of MZ twins, 40 and 100 years old, in two independent NGS experiments. They showed that somatic mutations detected between MZ twins were related to aging but the number of such variants were hardly found even in 100-year-old MZ twins.^[@bib37]^ Given that the GD twin in this study was 30 years old and the allele frequencies were different in MZ twins, the 3 mosaic mutations would have occurred in the developmental stage, not just as a consequence of aging. The result that we didn't detect any discordant somatic mutations in other elder twins may support this idea. Thus, further investigations including functional analysis and epidemiological analysis are needed to verify the significance of the mutations found in this study.

We also performed CNV detection by eXome-Hidden Markov Model analysis and validated candidate loci using the ddPCR system between MZ twin pairs. The ddPCR system yields absolute quantification and can easily detect small fold changes in CNVs, and is thus a suitable method for detecting the small fold of change in CNVs of somatic cell mosaic events.^[@bib38]^ Given that the results of our CNV analysis showed no differences in CNVs between discordant MZ twins, discordant CNVs between MZ twin pairs would be a rare event. Nonetheless, it is necessary to investigate CNV events because they would have a considerable impact on the biological process. Bruder *et al* reported a study in 19 pairs of MZ twins with either concordant or discordant phenotype using two platforms for genome-wide CNVs analyses. They showed the presence of CNVs within both groups.^[@bib6]^ Because these CNVs could be somatic cell mosaic mutations, mutant allele frequencies may be very low in samples and exact mosaic frequencies should be measured in affected tissues including brain tissue in the future.

In conclusion, we analyzed discordant variants in MZ twin pairs and one healthy control MZ twin using WES, and detected three somatic cell mosaic mutations in the GD twins by deep sequencing. It might be important to consider the presence of somatic cell mosaic mutations when confirming data obtained from WES. Furthermore, these somatic mosaic mutations might help to elucidate the pathogenesis of GD.
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![Discordant SNVs in GD MZ twin. (**a**) Electropherograms of discordant SNVs in GD twin. Mutant bases of GD-A barely confirmed in electropherograms. (**b**) Aligned reads visualized by IGV of discordant SNVs in GD twin. Mutant bases in aligned reads are displayed red and brown. Aligned reads show mutant bases clearly despite low allele frequency. (**c**) Aligned reads of resequencing analysis. Mutant bases of GD-A are conformed. Abbreviations: GD, gender dysphoria; IGV, Integrative Genomics Viewer; MZ, monozygotic; SNV, single-variant nucleotide.](hgv201732-f1){#fig1}

![Discordant CNV analysis. (**a**) Relative copy numbers of 8q24.3, 9q34.3, and *GNAS* gene as control. All loci of all samples show \~2 copies. No difference in copy number was confirmed between ASD-A and ASD-B. (**b**) Relative copy number of 14q32.33 and *GNAS* gene. Variable copy number is shown among samples at 14q32.33 (GD-A; 4.088, GD-B; 4.226, control-1; 7.286, control-2; 6.349). No difference in copy number was confirmed between GD-A and GD-B. Abbreviations: ASD, autism spectrum disorder; CNV, copy number variation; GD, gender dysphoria.](hgv201732-f2){#fig2}

###### Summary of samples in this study

  *Sample ID*              *Phenotype*              *Sex*   *Age at sample collection (years)*
  ------------- ---------------------------------- -------- ------------------------------------
  ASD-A              Autism spectrum disorder        Male   11
  ASD-B                       Normal                 Male   11
  ASD-Father                  Normal                 Male   50
  ASD-Mother                  Normal                Female  45
  GD-A           Gender disorder (male-to-female)    Male   30
  GD-B                        Normal                 Male   30
  Sc-11-A                 Schizophrenia              Male   41
  Sc-11-B                     Normal                 Male   41
  Sc-21-A                 Schizophrenia              Male   38
  Sc-21-B                     Normal                 Male   38
  Sc-51-A                 Schizophrenia              Male   41
  Sc-51-B                     Normal                 Male   41
  13A                         Normal                 Male   Unknown
  13B                         Normal                 Male   Unknown
  Control-1                   Normal                 Male   31
  Control-2                   Normal                 Male   38

Abbreviations: ASD, autism spectrum disorder; GD, gender dysphoria.

###### Summary of candidate discordant CNVs on XHMM analysis

  *Sample*            *Interval*           *CytoBand*   *XHMM analysis*   *Relative copy number (ddPCR/mean)*
  ---------- ---------------------------- ------------ ----------------- -------------------------------------
  ASD-A       chr8:144887409--145012081      8q24.3        Reference                  1.81548204
  ASD-B       chr8:144887409--145012081      8q24.3       Duplication                 1.916876751
  ASD-A       chr9:139902662--139912822      9q34.3        Reference                  2.236417293
  ASD-B       chr9:139902662--139912822      9q34.3       Duplication                 2.237732824
  GD-A        chr14:106330725--106405832    14q32.33       Reference                  4.088276371
  GD-B        chr14:106330725--106405832    14q32.33       Deletion                   4.226054708

Abbreviations: ASD, autism spectrum disorder; CNV, copy number variation; GD, gender dysphoria; XHMM, eXome-Hidden Markov Model.

###### *In silico* analysis of discordant SNVs in GD twin

  *Gene*          *Variants*        *cDNA change*   *Protein change*      *Polyphen2*          *PROVEAN*         *SIFT*     
  ---------- --------------------- --------------- ------------------ ------------------- ------------------- ------------- ----------
  *FBXO38*    chr5:147774428;T\>G     c.89T\>G         p.Met30Arg      Possibly damaging        Benign         Deleterious   Damaging
  *SMOC2*     chr6:169051385;A\>G     c.965A\>G       p.Glu322Gly      Probably damaging   Probably damaging   Deleterious   Damaging
  *TDRP*       chr8:442616;A\>G       c.341T\>C       p.Leu114Pro      Probably damaging   Probably damaging   Deleterious   Damaging

Abbreviations: GD, gender dysphoria; *SMOC2*, *SPARC*-related modular calcium-binding 2; SNV, single-variant nucleotide; *TDRP*, testis development-related protein.
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